Toran-Allerand C Dominique MD New York City, NY - 10032

Toran-Allerand C Dominique MD is categorized under Biological Research in New York City, NY and active since 2004.

Toran-Allerand C Dominique MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact C Dominique Toran-Allerand at the company’s single location by writing to 630 West 168th St, New York City, New York NY 10032 or by phoning (212) 305-3620. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Toran-Allerand C Dominique MD
Contact Person: C Dominique Toran-Allerand
Address: 630 West 168th St, New York City, New York 10032
Phone Number: (212) 305-3620
Annual Revenue (USD): $500.000 to $999.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Research
SIC Code: 8731
NAICS Code: 6211110
Share This Business:

Toran-Allerand C Dominique MD was started in 2004 to provide professional Biological Research under the SIC code 8731 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact C Dominique Toran-Allerand for inquiries that concern Toran-Allerand C Dominique MD by calling the company number (212) 305-3620, as your correspondence is most welcome. Additionally, the physical location of the single location of Toran-Allerand C Dominique MD can be found at the coordinates 40.841365,-73.940437 as well as the street address 630 West 168th St in New York City, New York 10032.

For its online presence, you may visit Toran-Allerand C Dominique MD’s website at and engage with its social media outlets through on Twitter and on Facebook.